The Cell and Immunology Core provides services that allow determination of effects of 1) drugs of abuse, 2) endogenous ligands which bind to the same receptors and transporters used by the drugs of abuse, or 3) infection with HIV or SIV or other opportunistic infections that are common in HIV, on cells of the immune system. The effects that are measured in the Core are functional endpoints which include responses of cells to mitogens; Natural Killer cell activity; capacity for in vitro antibody production; response in the Mixed Lymphocyte Reaction (MLR); and chemotaxis assays. In addition, the Core measures cytokine, chemokine, and neuropeptide levels in serum, plasma, cerebrospinal fluid, bronchial lavage fluid, peritoneal lavage fluid, or in supernatants of cell cultures, by a multiplex assay, or by ELISA assay for individual proteins. In addition, through support of the Flow Cytometry facility, the Core allows determination of effects of treatment with drugs of abuse or other related molecules, or infection, on numbers of immune cells in particular subsets, such as T-cells, CD4 and CD8 T-cells, B-cells, and monocyte/macrophages, Expression of cell surface markers, including receptors on primary cells or transfected cell lines, can also be quantitated on a per cell basis or as the percent of cells expressing a particular molecule. Intracellular expression of cytokines can be determined by flow cytometry. The Core also offers services to separate cells using magnetic bead technology, counter-current centrifugation using an elutriation centrifuge, or through sorting using the flow cytometer. Finally, the Core will screen cell lines for contamination with Mycoplasma.

Public Health Relevance

Exploration of neuroimmune connections is a major theme of the P30 Center. Several projects involve infection with SIV or HIV, combined with drugs of abuse or related molecules. The studies supported by the Core are providing fundamental new knowledge about the interactions of drugs of abuse on the immune system, and how the interactions regulate pain, body temperature, and HIV levels.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Center Core Grants (P30)
Project #
5P30DA013429-13
Application #
8375399
Study Section
Special Emphasis Panel (ZDA1-EXL-T)
Project Start
Project End
Budget Start
2012-05-01
Budget End
2013-04-30
Support Year
13
Fiscal Year
2012
Total Cost
$172,434
Indirect Cost
$57,478
Name
Temple University
Department
Type
DUNS #
057123192
City
Philadelphia
State
PA
Country
United States
Zip Code
19122
Bogush, Marina; Heldt, Nathan A; Persidsky, Yuri (2017) Blood Brain Barrier Injury in Diabetes: Unrecognized Effects on Brain and Cognition. J Neuroimmune Pharmacol 12:593-601
Howlett, Allyn C; Abood, Mary E (2017) CB1 and CB2 Receptor Pharmacology. Adv Pharmacol 80:169-206
Mooney, James; Rawls, Scott M (2017) KCNQ2/3 channel agonist flupirtine reduces cocaine place preference in rats. Behav Pharmacol 28:405-407
Kim, Jae; Connelly, Krista L; Unterwald, Ellen M et al. (2017) Chemokines and cocaine: CXCR4 receptor antagonist AMD3100 attenuates cocaine place preference and locomotor stimulation in rats. Brain Behav Immun 62:30-34
Gherghina, Florin Liviu; Tica, Andrei Adrian; Deliu, Elena et al. (2017) Effects of VPAC1 activation in nucleus ambiguus neurons. Brain Res 1657:297-303
Brailoiu, G Cristina; Deliu, Elena; Barr, Jeffrey L et al. (2017) HIV Tat excites D1 receptor-like expressing neurons from rat nucleus accumbens. Drug Alcohol Depend 178:7-14
Fakhouri, Lara; Cook, Christopher D; Al-Huniti, Mohammed H et al. (2017) Design, synthesis and biological evaluation of GPR55 agonists. Bioorg Med Chem 25:4355-4367
Merkel, Steven F; Andrews, Allison M; Lutton, Evan M et al. (2017) Trafficking of adeno-associated virus vectors across a model of the blood-brain barrier; a comparative study of transcytosis and transduction using primary human brain endothelial cells. J Neurochem 140:216-230
Merkel, Steven F; Cannella, Lee Anne; Razmpour, Roshanak et al. (2017) Factors affecting increased risk for substance use disorders following traumatic brain injury: What we can learn from animal models. Neurosci Biobehav Rev 77:209-218
Philogene-Khalid, Helene L; Hicks, Callum; Reitz, Allen B et al. (2017) Synthetic cathinones and stereochemistry: S enantiomer of mephedrone reduces anxiety- and depressant-like effects in cocaine- or MDPV-abstinent rats. Drug Alcohol Depend 178:119-125

Showing the most recent 10 out of 321 publications